We believe that digital health technologies are underutilized in managing human health. Developing patient-centric digital measures is complex, time-consuming and costly. Regulatory acceptance is difficult to achieve, hindering adoption.

 

DEEP seeks to connect, not compete.  We work with pharmaceutical organisations, technology companies, expert service providers, health authorities, academia and patient groups to advance the development and adoption of digital measures for use in clinical trials.